图表内容
TRV130的产品特点
Data in complex patients
New chemical entity
Elderly /obese
multiple comorbidities
Distinct from IV morphine
Simplified
predictable dosing
Olinvyk
IV opioid efficacy
No adjustment in renal impaired
Hard-and soft-tissue surgeries
No active metabolites
(oliceridine)injection
ell-characterized safety tolerability
Rapid analgesia
Studied in over 1
900 individuals
1-3 min median onset of pain relief
